Literature DB >> 21468036

Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia.

J Lu, Y Ma, N Kong, Z Alipio, C Gao, D S Krause, L E Silberstein, L Chai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468036      PMCID: PMC3675449          DOI: 10.1038/leu.2011.65

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.

Authors:  Catriona H M Jamieson; Laurie E Ailles; Scott J Dylla; Manja Muijtjens; Carol Jones; James L Zehnder; Jason Gotlib; Kevin Li; Markus G Manz; Armand Keating; Charles L Sawyers; Irving L Weissman
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

2.  Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.

Authors:  Jinqiu Zhang; Wai-Leong Tam; Guo Qing Tong; Qiang Wu; Hsiao-Yun Chan; Boon-Seng Soh; Yuefei Lou; Jianchang Yang; Yupo Ma; Li Chai; Huck-Hui Ng; Thomas Lufkin; Paul Robson; Bing Lim
Journal:  Nat Cell Biol       Date:  2006-09-17       Impact factor: 28.824

3.  SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.

Authors:  Yupo Ma; Wei Cui; Jianchang Yang; Jun Qu; Chunhui Di; Hesham M Amin; Raymond Lai; Jerome Ritz; Diane S Krause; Li Chai
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

4.  Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.

Authors:  In-kyung Park; Dalong Qian; Mark Kiel; Michael W Becker; Michael Pihalja; Irving L Weissman; Sean J Morrison; Michael F Clarke
Journal:  Nature       Date:  2003-04-20       Impact factor: 49.962

Review 5.  Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1.

Authors:  Frank M Raaphorst
Journal:  Trends Immunol       Date:  2003-10       Impact factor: 16.687

6.  The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia.

Authors:  Mohamad Mohty; Agnes S M Yong; Richard M Szydlo; Jane F Apperley; Junia V Melo
Journal:  Blood       Date:  2007-03-14       Impact factor: 22.113

7.  Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.

Authors:  Jianchang Yang; Li Chai; Fang Liu; Louis M Fink; Pei Lin; Leslie E Silberstein; Hesham M Amin; David C Ward; Yupo Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-08       Impact factor: 11.205

8.  The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.

Authors:  S Li; R L Ilaria; R P Million; G Q Daley; R A Van Etten
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

  8 in total
  20 in total

Review 1.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

2.  A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.

Authors:  Ailing Li; Youyang Yang; Chong Gao; Jiayun Lu; Ha-Won Jeong; Bee H Liu; Ping Tang; Xiaopan Yao; Donna Neuberg; Gang Huang; Daniel G Tenen; Li Chai
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

3.  SALL4 is a key transcription regulator in normal human hematopoiesis.

Authors:  Chong Gao; Nikki R Kong; Ailing Li; Hiro Tatetu; Shikiko Ueno; Youyang Yang; Jie He; Jianchang Yang; Yupo Ma; Grace S Kao; Daniel G Tenen; Li Chai
Journal:  Transfusion       Date:  2012-08-31       Impact factor: 3.157

Review 4.  The role of stem cell factor SALL4 in leukemogenesis.

Authors:  Chong Gao; Nikki R Kong; Li Chai
Journal:  Crit Rev Oncog       Date:  2011

Review 5.  SALL4, the missing link between stem cells, development and cancer.

Authors:  Hiro Tatetsu; Nikki R Kong; Gao Chong; Giovanni Amabile; Daniel G Tenen; Li Chai
Journal:  Gene       Date:  2016-02-16       Impact factor: 3.688

6.  SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.

Authors:  Marie Kroemer; Laurie Spehner; Patricia Mercier-Letondal; Laura Boullerot; Stefano Kim; Marine Jary; Jeanne Galaine; Emilie Picard; Christophe Ferrand; Thierry Nguyen; Fabrice Larosa; Olivier Adotévi; Yann Godet; Christophe Borg
Journal:  Oncoimmunology       Date:  2018-01-17       Impact factor: 8.110

7.  Malignant mixed mullerian tumor: an immunohistochemical study.

Authors:  Zhanyong Bing; Theresa Pasha; Li-Ping Wang; Paul J Zhang
Journal:  Patholog Res Int       Date:  2012-07-10

8.  Genome-wide pathway analysis reveals different signaling pathways between secreted lactoferrin and intracellular delta-lactoferrin.

Authors:  Byungtak Kim; Seongeun Kang; Sun Jung Kim
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

9.  The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia.

Authors:  Qi Shen; Sichu Liu; Junyan Hu; Shaohua Chen; Lijian Yang; Bo Li; Xiuli Wu; Yu Ma; Jianchang Yang; Yupo Ma; Yangqiu Li
Journal:  Cancer Cell Int       Date:  2012-10-15       Impact factor: 5.722

10.  Identification of Clinical Relevant Molecular Subtypes of Pheochromocytoma.

Authors:  Umair Ali Khan Saddozai; Fengling Wang; Muhammad Usman Akbar; Lu Zhang; Yang An; Wan Zhu; Longxiang Xie; Yongqiang Li; Xinying Ji; Xiangqian Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.